TXG Company Profile and Key Details
10x Genomics, Inc.
TXG Stock Price Chart
Stock Price Today
10x Genomics, Inc. (TXG) stock surged +0.93%, trading at $16.31 on NASDAQ, up from the previous close of $16.16. The stock opened at $16.06, fluctuating between $15.99 and $16.75 in the recent session.
Stock Snapshot
Stock Price History Chart
Contact Details
About Company
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression for measuring gene activity on a cell-by-cell basis; single cell immune profiling for measuring the activity of immune cells and their targets; single cell Assay for Transposase Accessible Chromati (ATAC) for measuring epigenetics comprising the physical organization of DNA; and single cell multiome ATAC + gene expression for measuring the genetic activity and epigenetic programming in the same cells across tens of thousands of cells in a single experiment. The company also provides visium spatial gene expression solution for measuring spatial gene expression patterns across a single tissue sample or gene expression and protein co-detection when combined with immunofluorescence. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.
Company Information
| Employees | 1259 |
| Beta | 1.87 |
| Sales or Revenue | $618.73M |
| 5Y Sales Change% | -0.517% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Medical - Healthcare Information Services |
Frequently Asked Questions
10x Genomics, Inc. (NASDAQ: TXG) stock price is $16.31 in the last trading session. During the trading session, TXG stock reached the peak price of $16.75 while $15.99 was the lowest point it dropped to. The percentage change in TXG stock occurred in the recent session was 0.93% while the dollar amount for the price change in TXG stock was $0.15.
The NASDAQ listed TXG is part of Medical - Healthcare Information Services industry that operates in the broader Healthcare sector. 10x Genomics, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Mr. James Bryant
Director of Legal
Mr. Nikhil Rao
Director of Product Management
Mr. Jonathan Schimmel
Vice President of Global Support & Sales Operations
Mr. Eric S. Whitaker Esq.
Chief Legal Officer
Ms. Rebecca Port
Chief People Officer
Mr. Justin J. McAnear
Chief Financial Officer
Dr. Benjamin J. Hindson Ph.D.
Co-Founder, Pres, Chief Scientific Officer & Director
Mr. Michael Schnall-Levin
Founding Scientist & Chief Technology Officer
Ms. Ruth De Backer
Chief Bus. Officer
Ms. Cassie Corneau
Mang. of Investor Relations and Strategic Fin.
Mr. Jim Wilbur Ph.D.
Chief Commercial Officer
Mr. James L. Wilbur Ph.D.
Chief Commercial Officer
Dr. Serge Saxonov Ph.D.
Co-Founder, Chief Executive Officer & Director
TXG's closing price is 25.95% higher than its 52-week low of $12.95 where as its distance from 52-week high of $51.22 is -68.16%.
Number of TXG employees currently stands at 1,259.
Official Website of TXG is: https://www.10xgenomics.com
TXG could be contacted at phone 925 401 7300 and can also be accessed through its website. TXG operates from 6230 Stoneridge Mall Road, Pleasanton, CA 94588-3260, United States.
TXG stock volume for the day was 1.38M shares. The average number of TXG shares traded daily for last 3 months was 1.92M.
The market value of TXG currently stands at $1.97B with its latest stock price at $16.31 and 121.05M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com